Ocular Application

Active molecules used in ophthalmic applications often suffer from poor permeability. LDS’s nano-sized domains create extensive interfacial contact with the eye epithelium upon topical drop instillation, dramatically enhancing permeation and improving delivery efficiency.

LDS’s technology enables: (1) effective targeting of both posterior and anterior eye segments and (2) the solubilization and delivery of relatively large molecular-weight active molecules.

Pre-clinical results demonstrating superiority